EAGLE ASSET MANAGEMENT INC - MIRATI THERAPEUTICS INC ownership

MIRATI THERAPEUTICS INC's ticker is MRTX and the CUSIP is 60468T105. A total of 290 filers reported holding MIRATI THERAPEUTICS INC in Q4 2020. The put-call ratio across all filers is 0.39 and the average weighting 0.6%.

Quarter-by-quarter ownership
EAGLE ASSET MANAGEMENT INC ownership history of MIRATI THERAPEUTICS INC
ValueSharesWeighting
Q3 2022$18,871,000
+4.7%
270,209
+0.6%
0.12%
+8.8%
Q2 2022$18,027,000
-16.4%
268,543
+2.3%
0.11%
+2.7%
Q1 2022$21,574,000
-43.8%
262,402
+1.4%
0.11%
-34.5%
Q4 2021$38,363,000
-16.4%
258,808
-0.3%
0.17%
-18.8%
Q3 2021$45,909,000
+13.3%
259,506
+15.1%
0.21%
+15.0%
Q1 2021$40,535,000
-16.1%
225,534
+2.5%
0.18%
-34.1%
Q4 2020$48,314,000
+17.5%
219,971
-11.2%
0.27%
+28.8%
Q3 2020$41,135,000
+30.3%
247,730
-10.0%
0.21%
+18.4%
Q2 2020$31,560,000
+41.8%
275,154
-5.0%
0.18%
+29.7%
Q1 2020$22,252,000
-39.9%
289,488
+0.8%
0.14%
-22.5%
Q4 2019$37,009,000287,2040.18%
Other shareholders
MIRATI THERAPEUTICS INC shareholders Q4 2020
NameSharesValueWeighting ↓
Aviva Holdings Ltd. 3,135,966$688,784,00067.42%
Avoro Capital Advisors LLC 4,535,000$996,067,00017.15%
Darwin Global Management, Ltd. 260,876$57,299,00015.99%
Boxer Capital, LLC 1,765,560$387,788,00012.46%
Perceptive Advisors 3,693,516$811,244,0008.71%
Consonance Capital Management LP 330,000$72,481,0006.77%
EcoR1 Capital, LLC 464,298$101,978,0005.48%
Fairmount Funds Management LLC 60,500$13,288,0004.75%
INTERNATIONAL BIOTECHNOLOGY TRUST PLC 67,400$14,804,0004.04%
RTW INVESTMENTS, LP 1,054,364$231,581,0003.88%
View complete list of MIRATI THERAPEUTICS INC shareholders